Latest filing published 10 Jul 2026 for Indivior Pharmaceuticals, Inc., €668k.
All filings by Heidbreder Christian on record concern Indivior Pharmaceuticals, Inc. We count 2 filings; the first trade dates from 11 June 2026 and the latest from 10 July 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 10 July 2026 came the latest disclosure, a transaction for €668k in Indivior Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations